Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 /PRNewswire/ -- Kimera Labs, Inc., the pioneer in therapeutic ...

A day of expert panels and prestigious honours for the UK's most impactful health innovations LONDON, May 8, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated ...

Preparations for the first analytica USA, the international trade fair for laboratory technology, analysis, biotechnology and ...

PI, a global leader in precision motion control and nanopositioning, announces fast delivery of its nanometer-precise, high-speed V-308 vertical nanopositioning stage. The system offers 7 mm of ...

Legend Biotech USA Inc. SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 billion merger deal with a special-purpose acquisition ...

RBC Capital analyst Leonid Timashev reiterated a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $84.00. The company’s shares closed yesterday at $32.24.

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

Financial Square Treasury Instruments Fund FST Shares FTIXX 29.42% Financial Square Government Fund FST Shares FGTXX 15.30% ...

Vivo Capital announced multiple legal proceedings to challenge the “irresponsible actions” taken by the current board of Directors of Sinovac Biotech (SVA) under the control of the activist ...